107 related articles for article (PubMed ID: 28495617)
1. The adaptor protein ARA55 and the nuclear kinase HIPK1 assist c-Myb in recruiting p300 to chromatin.
Bengtsen M; Sørensen L; Aabel L; Ledsaak M; Matre V; Gabrielsen OS
Biochim Biophys Acta Gene Regul Mech; 2017 Jul; 1860(7):751-760. PubMed ID: 28495617
[TBL] [Abstract][Full Text] [Related]
2. Mechanism of action of Hic-5/androgen receptor activator 55, a LIM domain-containing nuclear receptor coactivator.
Heitzer MD; DeFranco DB
Mol Endocrinol; 2006 Jan; 20(1):56-64. PubMed ID: 16141357
[TBL] [Abstract][Full Text] [Related]
3. HIPK1 interacts with c-Myb and modulates its activity through phosphorylation.
Matre V; Nordgård O; Alm-Kristiansen AH; Ledsaak M; Gabrielsen OS
Biochem Biophys Res Commun; 2009 Oct; 388(1):150-4. PubMed ID: 19646965
[TBL] [Abstract][Full Text] [Related]
4. The pioneer factor activity of c-Myb involves recruitment of p300 and induction of histone acetylation followed by acetylation-induced chromatin dissociation.
Fuglerud BM; Ledsaak M; Rogne M; Eskeland R; Gabrielsen OS
Epigenetics Chromatin; 2018 Jun; 11(1):35. PubMed ID: 29954426
[TBL] [Abstract][Full Text] [Related]
5. Hic-5/ARA55, a LIM domain-containing nuclear receptor coactivator expressed in prostate stromal cells.
Heitzer MD; DeFranco DB
Cancer Res; 2006 Jul; 66(14):7326-33. PubMed ID: 16849583
[TBL] [Abstract][Full Text] [Related]
6. Epithelial Hic-5/ARA55 expression contributes to prostate tumorigenesis and castrate responsiveness.
Li X; Martinez-Ferrer M; Botta V; Uwamariya C; Banerjee J; Bhowmick NA
Oncogene; 2011 Jan; 30(2):167-77. PubMed ID: 20818421
[TBL] [Abstract][Full Text] [Related]
7. Distinct LIM domains of Hic-5/ARA55 are required for nuclear matrix targeting and glucocorticoid receptor binding and coactivation.
Guerrero-Santoro J; Yang L; Stallcup MR; DeFranco DB
J Cell Biochem; 2004 Jul; 92(4):810-9. PubMed ID: 15211577
[TBL] [Abstract][Full Text] [Related]
8. PIAS1 binds p300 and behaves as a coactivator or corepressor of the transcription factor c-Myb dependent on SUMO-status.
Ledsaak M; Bengtsen M; Molværsmyr AK; Fuglerud BM; Matre V; Eskeland R; Gabrielsen OS
Biochim Biophys Acta; 2016 May; 1859(5):705-18. PubMed ID: 27032383
[TBL] [Abstract][Full Text] [Related]
9. The chromatin remodeling factor Mi-2alpha acts as a novel co-activator for human c-Myb.
Saether T; Berge T; Ledsaak M; Matre V; Alm-Kristiansen AH; Dahle O; Aubry F; Gabrielsen OS
J Biol Chem; 2007 May; 282(19):13994-4005. PubMed ID: 17344210
[TBL] [Abstract][Full Text] [Related]
10. Novel function of androgen receptor-associated protein 55/Hic-5 as a negative regulator of Smad3 signaling.
Wang H; Song K; Sponseller TL; Danielpour D
J Biol Chem; 2005 Feb; 280(7):5154-62. PubMed ID: 15561701
[TBL] [Abstract][Full Text] [Related]
11. FLASH acts as a co-activator of the transcription factor c-Myb and localizes to active RNA polymerase II foci.
Alm-Kristiansen AH; Saether T; Matre V; Gilfillan S; Dahle O; Gabrielsen OS
Oncogene; 2008 Aug; 27(34):4644-56. PubMed ID: 18408764
[TBL] [Abstract][Full Text] [Related]
12. Naphthol AS-E Phosphate Inhibits the Activity of the Transcription Factor Myb by Blocking the Interaction with the KIX Domain of the Coactivator p300.
Uttarkar S; Dukare S; Bopp B; Goblirsch M; Jose J; Klempnauer KH
Mol Cancer Ther; 2015 Jun; 14(6):1276-85. PubMed ID: 25740244
[TBL] [Abstract][Full Text] [Related]
13. Roles of HIPK1 and HIPK2 in AML1- and p300-dependent transcription, hematopoiesis and blood vessel formation.
Aikawa Y; Nguyen LA; Isono K; Takakura N; Tagata Y; Schmitz ML; Koseki H; Kitabayashi I
EMBO J; 2006 Sep; 25(17):3955-65. PubMed ID: 16917507
[TBL] [Abstract][Full Text] [Related]
14. A SUMO-regulated activation function controls synergy of c-Myb through a repressor-activator switch leading to differential p300 recruitment.
Molvaersmyr AK; Saether T; Gilfillan S; Lorenzo PI; Kvaløy H; Matre V; Gabrielsen OS
Nucleic Acids Res; 2010 Aug; 38(15):4970-84. PubMed ID: 20385574
[TBL] [Abstract][Full Text] [Related]
15. A Dual-Site Inhibitor of CBP/p300 KIX is a Selective and Effective Modulator of Myb.
Joy ST; Henley MJ; De Salle SN; Beyersdorf MS; Vock IW; Huldin AJL; Mapp AK
J Am Chem Soc; 2021 Sep; 143(37):15056-15062. PubMed ID: 34491719
[TBL] [Abstract][Full Text] [Related]
16. Human T-cell lymphotropic virus type 1 Tax represses c-Myb-dependent transcription through activation of the NF-kappaB pathway and modulation of coactivator usage.
Nicot C; Mahieux R; Pise-Masison C; Brady J; Gessain A; Yamaoka S; Franchini G
Mol Cell Biol; 2001 Nov; 21(21):7391-402. PubMed ID: 11585920
[TBL] [Abstract][Full Text] [Related]
17. Suppression of androgen receptor transactivation by Pyk2 via interaction and phosphorylation of the ARA55 coregulator.
Wang X; Yang Y; Guo X; Sampson ER; Hsu CL; Tsai MY; Yeh S; Wu G; Guo Y; Chang C
J Biol Chem; 2002 May; 277(18):15426-31. PubMed ID: 11856738
[TBL] [Abstract][Full Text] [Related]
18. Small-Molecule Disruption of the Myb/p300 Cooperation Targets Acute Myeloid Leukemia Cells.
Uttarkar S; Piontek T; Dukare S; Schomburg C; Schlenke P; Berdel WE; Müller-Tidow C; Schmidt TJ; Klempnauer KH
Mol Cancer Ther; 2016 Dec; 15(12):2905-2915. PubMed ID: 27707899
[TBL] [Abstract][Full Text] [Related]
19. Interaction of the tau2 transcriptional activation domain of glucocorticoid receptor with a novel steroid receptor coactivator, Hic-5, which localizes to both focal adhesions and the nuclear matrix.
Yang L; Guerrero J; Hong H; DeFranco DB; Stallcup MR
Mol Biol Cell; 2000 Jun; 11(6):2007-18. PubMed ID: 10848625
[TBL] [Abstract][Full Text] [Related]
20. Endothelin-1-dependent nuclear factor of activated T lymphocyte signaling associates with transcriptional coactivator p300 in the activation of the B cell leukemia-2 promoter in cardiac myocytes.
Kawamura T; Ono K; Morimoto T; Akao M; Iwai-Kanai E; Wada H; Sowa N; Kita T; Hasegawa K
Circ Res; 2004 Jun; 94(11):1492-9. PubMed ID: 15117818
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
